Pancreatic Cancer Research

ResearcherState Key Laboratory of Genetic EngineeringActive in the last 2 years

Qing Yang

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0003-4162-922X; OpenAlex author ID A5046899960.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
1
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Tryptophan deficiency induced by indoleamine 2,3-dioxygenase 1 results in glucose transporter 1-dependent promotion of aerobic glycolysis in pancreatic cancer. Last author DOI 10.1002/mco2.555↗
  2. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer. Last author DOI 10.1016/j.canlet.2021.09.012↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Heng Liang · 2 shared papers, 2021–2024

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.